Department of Pathology, University of Otago, Dunedin 9016, New Zealand.
Tuberous Sclerosis Complex-New Zealand, New Zealand.
Cold Spring Harb Mol Case Stud. 2022 Apr 28;8(3). doi: 10.1101/mcs.a006182. Print 2022 Apr.
Tuberous sclerosis complex (TSC) is an inheritable disorder characterized by the formation of benign yet disorganized tumors in multiple organ systems. Germline mutations in the (hamartin) or more frequently (tuberin) genes are causative for TSC. The malignant manifestations of TSC, pulmonary lymphangioleiomyomatosis (LAM) and renal angiomyolipoma (AML), may also occur as independent sporadic perivascular epithelial cell tumor (PEComa) characterized by somatic mutations. Thus, discerning TSC from the copresentation of sporadic LAM and sporadic AML may be obscured in TSC patients lacking additional features. In this report, we present a case study on a single patient initially reported to have sporadic LAM and a mucinous duodenal adenocarcinoma deficient in DNA mismatch repair proteins. Moreover, the patient had a history of Wilms' tumor, which was reclassified as AML following the LAM diagnosis. Therefore, we investigated the origins and relatedness of these tumors. Using germline whole-genome sequencing, we identified a premature truncation in one of the patient's alleles. Using immunohistochemistry, loss of tuberin expression was observed in AML and LAM tissue. However, no evidence of a somatic loss of heterozygosity or DNA methylation epimutations was observed at the locus, suggesting alternate mechanisms may contribute to loss of the tumor suppressor protein. In the mucinous duodenal adenocarcinoma, no causative mutations were found in the DNA mismatch repair genes , or Rather, clonal deconvolution analyses were used to identify mutations contributing to pathogenesis. This report highlights both the utility of using multiple sequencing techniques and the complexity of interpreting the data in a clinical context.
结节性硬化症(TSC)是一种遗传性疾病,其特征是多个器官系统中良性但紊乱的肿瘤形成。 (错构瘤蛋白)或更常见的 (结节性硬化症蛋白)基因的种系突变是 TSC 的致病原因。 TSC 的恶性表现,如肺淋巴管肌瘤病(LAM)和肾血管平滑肌脂肪瘤(AML),也可能作为独立的散发性血管周上皮细胞肿瘤(PEComa)发生,其特征是体细胞 突变。因此,在缺乏其他特征的 TSC 患者中,TSC 与散发性 LAM 和散发性 AML 的共表达可能会被混淆。在本报告中,我们介绍了一个单一患者的病例研究,该患者最初被报告为散发性 LAM 和缺乏 DNA 错配修复蛋白的黏液性十二指肠腺癌。此外,该患者有肾母细胞瘤病史,在 LAM 诊断后被重新归类为 AML。因此,我们研究了这些肿瘤的起源和相关性。使用种系全基因组测序,我们在患者的一个 等位基因中发现了一个提前的截断。使用免疫组织化学,在 AML 和 LAM 组织中观察到结节性硬化症蛋白表达缺失。然而,在 基因座未观察到体细胞杂合性丢失或 DNA 甲基化表观遗传突变的证据,这表明替代机制可能有助于肿瘤抑制蛋白的丢失。在黏液性十二指肠腺癌中,未发现 DNA 错配修复基因 或 中的致病突变。相反,使用克隆去卷积分析鉴定了导致发病机制的突变。本报告强调了在临床环境中使用多种测序技术的实用性和解释数据的复杂性。